Michel Lemaire

2.9k total citations
62 papers, 2.4k citations indexed

About

Michel Lemaire is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Transplantation. According to data from OpenAlex, Michel Lemaire has authored 62 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 17 papers in Pediatrics, Perinatology and Child Health and 12 papers in Transplantation. Recurrent topics in Michel Lemaire's work include Drug Transport and Resistance Mechanisms (22 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Renal Transplantation Outcomes and Treatments (12 papers). Michel Lemaire is often cited by papers focused on Drug Transport and Resistance Mechanisms (22 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Renal Transplantation Outcomes and Treatments (12 papers). Michel Lemaire collaborates with scholars based in Japan, Switzerland and France. Michel Lemaire's co-authors include J.P. Tillement, Gerald Maurer, Armin Bruelisauer, Andrew Crowe, Peter Marbach, William F. Elmquist, Michael Hayes, Tetsuya Terasaki, Gian Camenisch and Werner Niederberger and has published in prestigious journals such as Journal of Clinical Microbiology, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Michel Lemaire

60 papers receiving 2.3k citations

Peers

Countries citing papers authored by Michel Lemaire

Since Specialization

Citations

This map shows the geographic impact of Michel Lemaire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Lemaire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Lemaire more than expected).

Fields of papers citing papers by Michel Lemaire

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Lemaire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Lemaire. The network helps show where Michel Lemaire may publish in the future.

Co-authorship network of co-authors of Michel Lemaire

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Lemaire. A scholar is included among the top collaborators of Michel Lemaire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Lemaire. Michel Lemaire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Modulation of the Brain Distribution of Imatinib and its Metabolites in Mice by Valspodar, Zosuquidar and Elacridar 2007 ·Pharmaceutical Research ·(unknown), Gian Camenisch, Michel Lemaire, Jean‐Michel Scherrmann	60
2	Influence of breast cancer resistance protein (Abcg2) and p‐glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec^®) across the mouse blood–brain barrier 2007 ·Journal of Neurochemistry ·(unknown), Gian Camenisch, Michel Lemaire, Jean‐Michel Scherrmann	79
3	ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: Identification, in vitro pharmacology, pharmacokinetic and biodistribution studies 2006 ·Bioorganic & Medicinal Chemistry ·Samuel Hintermann, Ivo Vranesic, Hans Allgeier, (unknown), Daniël Hoyer, Michel Lemaire, (unknown), Stephan Urwyler, Steven Whitebread, F. Gasparini, Yves P. Auberson	55
4	Influence of Hydroxyurea On Imatinib Mesylate (Gleevec) Transport at the Mouse Blood-Brain Barrier 2006 ·Drug Metabolism and Disposition ·(unknown), Gian Camenisch, Gerhard Groß, Michel Lemaire, Jean‐Michel Scherrmann	18
5	Distribution of STI-571 to the Brain Is Limited by P-Glycoprotein-Mediated Efflux 2003 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), Peter Marbach, Michel Lemaire, Michael Hayes, William F. Elmquist	225
6	Characterization of the Transport of a Cationic Octapeptide, Octreotide, in Rat Bile Canalicular Membrane: Possible Involvement of P-Glycoprotein. 1998 ·Biological and Pharmaceutical Bulletin ·Tadashi Yamada, Yukio Kato, Hiroyuki Kusuhara, Michel Lemaire, Yuichi Sugiyama	15
7	Role of lipoproteins in the plasma binding of SDZ PSC 833, a novel multidrug resistance‐reversing cyclosporin 1998 ·British Journal of Clinical Pharmacology ·Nicolas Simon, Éric Dailly, (unknown), Emmanuelle Malaurie, Michel Lemaire, Jean‐Paul Tillement, Saı̈k Urien	20
8	In Vitro and In Situ Absorption of SDZ-RAD Using a Human Intestinal Cell Line (Caco-2) and a Single Pass Perfusion Model in Rats: Comparison with Rapamycin 1998 ·Pharmaceutical Research ·Andrew Crowe, Michel Lemaire	102
9	Effect of the P-glycoprotein inhibitor, SDZ PSC 833, on the blood and brain pharmacokinetics of colchicine 1997 ·Life Sciences ·Sandrine Desrayaud, (unknown), Jean‐Michel Scherrmann, Michel Lemaire	49
10	Modeling the Route of Administration-Based Enhancement in the Brain Delivery of EAB 515, Studied by Microdialysis 1997 ·Journal of drug targeting ·Bimal Malhotra, Richard C. Brundage, Michel Lemaire, Ronald J. Sawchuk	4
11	High-performance liquid chromatographic analysis of (S)-α-amino-5-phosphonomethyl[1,1′-biphenyl]-3-propanoic acid (EAB 515) in brain and blood microdialysate (on-line) and in plasma ultrafiltrate of freely moving rats 1996 ·Journal of Chromatography B Biomedical Sciences and Applications ·Bimal Malhotra, Michel Lemaire, (unknown), Ronald J. Sawchuk	5
12	Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-Methyl-D-aspartate receptor antagonists—II. Pharmacological characterization in vivo 1996 ·Neuropharmacology ·Stephan Urwyler, Elizabeth Campbell, Gert Fricker, Peter Jenner, Michel Lemaire, Kevin H. McAllister, H.C. Neijt, Chun Kun Park, Martin Perkins, Markus Rudin, André Sauter, Lance A. Smith, Karl‐Heinz Wiederhold, Werner Müller	27
13	Role of P‐Glycoprotein in the Blood‐Brain Transport of Colchicine and Vinblastine 1996 ·Journal of Neurochemistry ·(unknown), Michel Lemaire, Jeanne-Marie Lefauconnier, J.M. Scherrmann	88
14	Hepatic uptake of octreotide, a long-acting somatostatin analogue, via a bile acid transport system. 1995 ·Pharmaceutical Research ·Tetsuya Terasaki, Hiroyuki Mizuguchi, (unknown), Ikumi Tamai, Michel Lemaire, Akira Tsuji	20
15	Physiologically based pharmacokinetic modeling as a tool for drug development 1995 ·Journal of Pharmacokinetics and Biopharmaceutics ·(unknown), Ryosei Kawai, Jerry Nedelman, Michel Lemaire, Werner Niederberger, Hitoshi Sato	50
16	Microdialysis Sampling to Determine the Pharmacokinetics of Unbound SDZ ICM 567 in Blood and Brain in Awake, Freely-Moving Rats 1995 ·Pharmaceutical Research ·María J. Alonso, Armin Bruelisauer, (unknown), Michel Lemaire	15
17	Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125 1994 ·Journal of Pharmacokinetics and Biopharmaceutics ·Ryosei Kawai, Michel Lemaire, Jean‐Louis Steimer, Armin Bruelisauer, Werner Niederberger, Malcolm Rowland	123
18	Investigation of the Distribution of EAB 515 to Cortical ECF and CSF in Freely Moving Rats Utilizing Microdialysis 1994 ·Pharmaceutical Research ·Bimal Malhotra, Michel Lemaire, Ronald J. Sawchuk	30
19	From Somatostatin to Sandostatin®: Pharmacodynamics and Pharmacokinetics 1993 ·Digestion ·Peter Marbach, U. Briner, Michel Lemaire, A. Schweitzer, Tetsuya Terasaki	17
20	Disposition of sandostatin, a new synthetic somatostatin analogue, in rats. 1989 ·Drug Metabolism and Disposition ·Michel Lemaire, M. Azria, (unknown), Peter Marbach, A. Schweitzer, Gerald Maurer	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact